Double-Blind, Placebo-Controlled, Parallel Group Comparison Study for the Effect of Daily Ingestion of "Sarasara Gold" extract from onions produced in Hokkaido in the Improvement of Glucose Metabolism

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000019175
• Lead Sponsor: Hokkaido Information University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-09-30
• Study Completion: 2015-12-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are under treatment, medication and life-style advice for diabetes by doctors. 2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal, endocrine and metabolic disorders and/or affected with an infectious disease which is required to report to the authorities. 3. Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy and/ or other serious gastrointestinal surgeries. 4. Subjects with abnormal blood pressure or hematological data 5. Subjects with serious anemia 6. Pre- or post-menopausal subjects having complaints of obvious physical changes 7. Subjects who are allergic to foods, especially onions and gelatin. 8. Subjects regularly take medicine, functional foods and/or supplements including dietary fiber such as indigestible dextrin etc., and/or polyphenol, etc. which would affect the blood glucose. 9. Heavy smokers, chronic alcohol drinkers and/or subjects with irregular lifestyle. 10. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood components within 2 weeks prior to screening. 11. Subjects who are pregnant or expected to be pregnant, or lactating during the study. 12. Subjects who participate in other clinical trials within the last one month prior to the current clinical trial. 13. Any other medical reasons judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified